Pancreatic Cancer and Diabetes Mellitus

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorShanghai Changzheng Hospital

About this trial

The goal of this observational study is to learn about post-surgery of pancreatic cancer diabetes mellitus.The main questions it aims to answer are:

1. Are the incident rates of glucose metabolic disorders (pre-diabetes and diabetes mellitus) after pancreatic cancer of different etiologies the same? 2. Are alterations in endocrine and exdocrine secretory function in patients with pancreatic surgery associated with all-round outcomes? All patients with pancreatic surgery have been given the standardized treatment for the condition.

The reasearchers will summarize the incident rates of glucose metabolic disorders (pre-diabetes and diabetes mellitus) during different surgical procedures to explore the association between alternations in endocrine and exdocrine secrectory function and all-round outcomes.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

patients with pancreatic cancer after pancreatic surgery

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • All enrolled subjects completed dynamic blood glucose monitoring to obtain continuous peripheral blood glucose data.

    Diagnostic test

    All enrolled subjects completed dynamic blood glucose monitoring to obtain continuous peripheral blood glucose data.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Number of Participants Who developed glucose metabolic disorders(pre-diabetes and diabetes mellitus)

The diagnosis of glucose disorders should be made applying criteria of the American Diabetes Association.

Time frame
From enrollment to five years after the end of the surgery

Secondary outcomes

1

Overall Survival

Time frame
From enrollment to five years after the end of the surgery
2

Disease-Free Survival

Time frame
From enrollment to five years after the end of the surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.